Tenofovir Use in Human Immunodeficiency Virus-1–Infected Children in the United Kingdom and Ireland

Greater Tenofovir‐Associated Renal Function Decline with Protease Inhibitor–Based versus Nonnucleoside Reverse‐Transcriptase Inhibitor–Based Therapy

2007 • 301 citations

Update of the drug resistance mutations in HIV-1: 2007.

2007 • 275 citations

Decline in mortality, AIDS, and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and Ireland

2003 • 225 citations

Morbidity, Mortality, and Response to Treatment by Children in the United Kingdom and Ireland with Perinatally Acquired HIV Infection during 1996-2006: Planning for Teenage and Adult Care

2007 • 202 citations

Time trends in primary resistance to HIV drugs in the United Kingdom: multicentre observational study

2005 • 177 citations

Tenofovir-Associated Fanconi Syndrome: Review of the FDA Adverse Event Reporting System

2008 • 170 citations

Tenofovir Disoproxil Fumarate and an Optimized Background Regimen of Antiretroviral Agents as Salvage Therapy: Impact on Bone Mineral Density in HIV-Infected Children

2006 • 165 citations

Severe Renal Dysfunction and Risk Factors Associated with Renal Impairment in HIV‐Infected Adults in Africa Initiating Antiretroviral Therapy

2008 • 156 citations

Pharmacokinetics and Safety of Tenofovir Disoproxil Fumarate on Coadministration With Lopinavir/Ritonavir

2006 • 142 citations

Decreased Bone Mineral Density with Off-Label Use of Tenofovir in Children and Adolescents Infected with Human Immunodeficiency Virus

2008 • 130 citations

PENTA guidelines for the use of antiretroviral therapy, 2004

2004 • 130 citations

Unexpected CD4 cell count decline in patients receiving didanosine and tenofovir-based regimens despite undetectable viral load

2004 • 116 citations

Underdosing of antiretrovirals in UK and Irish children with HIV as an example of problems in prescribing medicines to children, 1997-2005: cohort study

2006 • 101 citations

Exploring Mitochondrial Nephrotoxicity as a Potential Mechanism of Kidney Dysfunction among HIV-Infected Patients on Highly Active Antiretroviral Therapy

2006 • 96 citations

Tenofovir Disoproxil Fumarate and an Optimized Background Regimen of Antiretroviral Agents as Salvage Therapy for Pediatric HIV Infection

2005 • 92 citations

K65R, TAMs and tenofovir.

2004 • 89 citations

A 12-Month Treatment With Tenofovir Does Not Impair Bone Mineral Accrual in HIV-Infected Children

2005 • 60 citations

Drug‐Drug and Drug‐Food Interactions Between Tenofovir Disoproxil Fumarate and Didanosine

2005 • 58 citations

BHIVA guidelines on HIV and chronic hepatitis: coinfection with HIV and hepatitis C virus infection (2005)

2005 • 48 citations

Nephrotoxicity in a child with perinatal HIV on tenofovir, didanosine and lopinavir/ritonavir

2006 • 41 citations

Renal Safety of Tenofovir in HIV-infected Children

2007 • 41 citations

HIV-1 DRUG RESISTANCE IN HIV-1-INFECTED CHILDREN IN THE UNITED KINGDOM FROM 1998 TO 2004

2008 • 35 citations

Suboptimal CD4 gains in HIV-infected patients receiving didanosine plus tenofovir

2006 • 34 citations

Dose-dependent influence of didanosine on immune recovery in HIV-infected patients treated with tenofovir

2005 • 32 citations

BHIVA guidelines on HIV and chronic hepatitis: coinfection with HIV and hepatitis B virus infection (2005)

2005 • 17 citations

Short-Term Safety and Tolerability of Didanosine Combined with High- versus Low-Dose Tenofovir Disproxil Fumarate in Ambulatory HIV-1–Infected Persons

2006 • 13 citations

Intimacy and Responsibility: The Criminalization of HIV Transmission by Author: Dr Matthew Weait

2008 • 3 citations